4//SEC Filing
Clendeninn Neil James 4
Accession 0001209191-13-028948
CIK 0000949858other
Filed
May 27, 8:00 PM ET
Accepted
May 28, 12:25 PM ET
Size
12.1 KB
Accession
0001209191-13-028948
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Award
Stock Option (right to buy)
2013-05-24+5,000→ 5,000 totalExercise: $10.73Exp: 2023-05-24→ Common Stock (5,000 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2013-05-23−2,000→ 0 totalFrom: 2013-05-23Exp: 2013-06-21→ Common Stock (2,000 underlying) - Award
Restricted Stock Unit (RSU)
2013-05-24+2,500→ 2,500 total→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2013-05-23$10.64/sh+2,000$21,280→ 9,562 total
Footnotes (5)
- [F1]Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock at settlement.
- [F3]The options vest 100% on the earlier of May 24, 2014 or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F4]The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F5]The restricted stock units expire 30 days from the earlier of the first anniversary of the grant date or the date of the issuer's next annual meeting of stockholders.
Documents
Issuer
ONCOGENEX PHARMACEUTICALS, INC.
CIK 0000949858
Entity typeother
Related Parties
1- filerCIK 0001442443
Filing Metadata
- Form type
- 4
- Filed
- May 27, 8:00 PM ET
- Accepted
- May 28, 12:25 PM ET
- Size
- 12.1 KB